118399-28-3

Basic information

• Product Name: Benzyl (R)-5-oxotetrahydrofuran-3-ylcarbamate
• Synonyms: (R)-BENZYL-5-OXO-TETRAHYDROFURAN-3-YL CARBAMATE;BENZYL (R)-5-OXOTETRAHYDROFURAN-3-YLCARBAMATE;N-[(3R)-Tetrahydro-5-oxo-3-furanyl]carbamic acid phenylmethyl ester;3(R)-[(Carbobenzyloxy)amino]-γ-butyrolactone;Cbz-R-3-Amino-γ-butyrolactone;(R)-3-(Cbz-aMino)-5-oxotetrahydrofuran;(R)-4-benzyloxycarbonylaMino-4,5-dihydro-2(3H)-furanone 10g;(R)-4-(Cbz-aMino)-2-oxotetrahydrofuran
• CAS NO: 118399-28-3
• Molecular Formula: C₁₂H₁₃NO₄
• Molecular Weight: 235.23592
• EINECS: 821-246-2
• Product Categories: chiral;Chiral Reagents;Amino Acids & deravitives;Aromatics;Heterocycles;Miscellaneous Reagents
• Mol File: 118399-28-3.mol
• Article Data: 14

Chemical Properties

• Melting Point: 105.0 to 109.0 °C
• Boiling Point: 466.087 °C at 760 mmHg
• Flash Point: 235.681 °C
• Appearance: Off-white solid
• Density: 1.27
• Vapor Pressure: 7.29E-09mmHg at 25°C
• Refractive Index: 1.56
• Storage Temp.: 2-8°C
• Solubility: Chloroform, Dichloromethane, Ethyl Acetate, Methanol
• PKA: 10.87±0.20(Predicted)
• CAS DataBase Reference: Benzyl (R)-5-oxotetrahydrofuran-3-ylcarbamate(CAS DataBase Reference)
• NIST Chemistry Reference: Benzyl (R)-5-oxotetrahydrofuran-3-ylcarbamate(118399-28-3)
• EPA Substance Registry System: Benzyl (R)-5-oxotetrahydrofuran-3-ylcarbamate(118399-28-3)

Safety Data

• Hazard Codes: Xi
• Safety Statements: 24/25
• HazardClass: IRRITANT
• Hazardous Substances Data: 118399-28-3(Hazardous Substances Data)

Usage

Chemical Properties

Off-White Solid

Uses

3(R)-[(Carbobenzyloxy)amino]-γ-butyrolactone (cas# 118399-28-3) is a compound useful in organic synthesis.

InChI:InChI=1/C12H13NO4/c14-11-6-10(8-16-11)13-12(15)17-7-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H,13,15)/t10-/m1/s1

Upstream product

• 105183-60-6 (S)-benzyl 2-((tert-butoxycarbonyl)amino)-4-hydroxybutanoate 
• 130369-36-7 N-(Benzyloxycarbonyl)-3-amino-1-cyclobutanone 
• 1256257-81-4 C₁₄H₁₃F₃N₂O₅ 
• 30925-18-9 2-tert-butoxycarbonylamino-succinic acid 1-benzyl ester 
• 135517-09-8 ((1S,2R)-3-Benzylcarbamoyl-2-benzyloxycarbonylamino-1-hydroxymethyl-propyl)-carbamic acid tert-butyl ester 
• 78663-07-7 N-(benzyloxycarbonyl)-D-aspartic acid 
• 1783-96-6 (2R)-aspartic acid 
• 501-53-1 benzyl chloroformate 
• 123673-31-4 (R)-3-(benzyloxycarbonylamino)-4-hydroxybutanoic acid 
• 75443-62-8 benzyl N-[(3R)-2,5-dioxotetrahydrofuran-3-yl]carbamate 

Downstream Products

• 318249-44-4 Methylester of (R)-4-hydroxy-3-(benzyloxycarbonylamino) Butanoic Acid 
• 1357575-01-9 (R)-methyl 3-(benzyloxycarbonylamino)-4-(phenylthio)butanoate 
• 870812-93-4 benzyl (1R)-3-(4-morpholinyl)-3-oxo-1-((phenylsulfanyl)methyl)propylcarbamate 
• 870812-30-9 benzyl {(1R)-3-(dimethylamino)-3-oxo-1-[(phenylthio)methyl]propyl}carbamate 
• 921752-04-7 benzyl [(3R,4R)-4-allyl-5-oxotetrahydrofuran-3-yl]carbamate 
• 921751-96-4 C₂₄H₂₆F₃N₃O₅ 
• 1012059-95-8 (R)-benzyl 1-hydroxy-4-(methylamino)-4-oxobutan-2-ylcarbamate 
• 152783-42-1 (R)-4-benzylamino-4,5-dihydro-2(3H)-furanone 
• 896123-15-2 benzyl (2-hydroxy-(1R)-1-{[2-fluoro-4-(3-oxomorpholin-4-yl)phenylcarbamoyl]methyl}ethyl)carbamate 
• 870812-29-6 benzyl (1R)-3-(dimethylamino)-1-(hydroxymethyl)-3-oxopropylcarbamate 
• 870812-92-3 benzyl (1R)-1-(hydroxymethyl)-3-(4-morpholinyl)-3-oxopropylcarbamate 
• 349148-58-9 (2R,3R)-N-methoxy-N-methyl-2-benzyl-3-(benzyloxycarbonylamino)-4-hydroxybutanamide 
• 349148-60-3 (2R,3R)-N-methoxy-N-methyl-2-benzyl-3,4-(benzyloxycarbonylimino)-butanamide 
• 152580-30-8 (R)-β-amino-γ-butyrolactone 

Relevant articles and documents

INHIBITING B-CELL LYMPHOMA 2 (BCL-2) AND RELATED PROTEINS

Novel compounds inhibiting anti-apoptosis proteins B-cell lymphoma 2 (Bcl-2) and Bcl-XL include compounds of formula (I) and formula (II) disclosed herein, as well as liposome compositions comprising Bcl-2 inhibitor compounds. These compositions are usefu

CHEMICAL COMPOUNDS

The present invention relates to compounds of Formula (I): and to their salts, pharmaceutical compositions, methods of use, and methods for their preparation. These compounds inhibit Bcl-2 and/or Bcl-XL activities and may be used for the treatment of cancer.

Design and synthesis of some new quinoline-3-carbohydrazone derivatives as potential antimycobacterial agents

A series of 26 new quinoline derivatives carrying active pharmacophores has been synthesized and evaluated for their in vitro antituberculosis activity against Mycobacterium tuberculosis H37Rv (MTB), Mycobacterium smegmatis (MC2), and Mycobacterium fortuitum following the broth micro dilution assay method. Compounds 13e, 13i, 13k, 14a, 14c, 14i, and 14k exhibited significant minimum inhibition concentrations, when compared with first line drugs isoniazid (INH) and rifampicin (RIF) and could be ideally suited for further modifications to obtain more efficacious compounds in the fight against multi-drug resistant tuberculosis.